FrieslandCampina said its 2â-fucosyllactose trademarked Aequival has been approved by Australiaâs and New Zealandâs authorities for use in infant milk formula, and that it is on track in expanding its human milk oligosaccharide (HMO) portfolio…
阅读更多（Read More）
FrieslandCampina secures 2’-FL approval in ANZ, eyes HMO portfolio expansion
作者mkymarcia5629554
11 月 1, 2022